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Abstract
Introduction:  Several  mitochondrial  DNA  mutations  have  been  reported  to  be  associated  with
nonsyndromic  hearing  loss  in  several  families.  However,  little  is  known  about  the  prevalence  of
these mutations  in  sporadic  patients  with  nonsyndromic  sensorineural  hearing  loss.
Objective:  The  purpose  of  our  study  was  to  investigate  the  incidence  of  these  mitochondrial
DNA mutations  in  such  population.
Methods:  A  total  of  178  sporadic  patients  with  nonsyndromic  sensorineural  hearing  loss  were
enrolled in  this  study.  Genomic  DNA  was  extracted  from  the  peripheral  blood  sample.  We
employed  the  SNaPshot® sequencing  method  to  detect  ﬁve  mitochondrial  DNA  mutations,
including  A1555G  and  A827G  in  12S  rRNA  gene  and  A7445G,  7472insC,  and  T7511C  in  tRNASer(UCN)
gene.  Meanwhile,  we  used  polymerase  chain  reaction  and  sequenced  the  products  to  screen
GJB2 gene  mutations  in  patients  carrying  mitochondrial  DNA  mutations.
Results:  We  failed  to  detect  the  presence  of  A1555G  mutation  in  12S  rRNA  gene,  and  of  A7445G,
7472insC, T7511C  mutations  in  tRNASer(UCN) gene  in  our  population.  However,  we  found  that  6
patients (3.37%)  were  carriers  of  a  homozygous  A827G  mutation  and  one  of  them  also  carried
homozygous  GJB2  235delC  mutation.
Conclusion:  Our  ﬁndings  in  the  present  study  indicate  that  even  in  sporadic  patients  with  non-
syndromic sensorineural  hearing  loss,  mitochondrial  DNA  mutations  might  also  contribute  to  the
clinical  phenotype.
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Prevalência  de  mutac¸ões  no  DNA  mitocondrial  em  pacientes  esporádicos  com
deﬁciência  auditiva  sensorioneural  não  sindrômica
Resumo
Introduc¸ão:  Diversas  mutac¸ões  do  DNA  mitocondrial  tem  sido  descritas,  em  diferentes  famílias,
associadas  à  deﬁciência  auditiva  não  sindrômica.  No  entanto,  pouco  se  sabe  sobre  a  prevalên-
cia dessas  mutac¸ões  em  pacientes  esporádicos  com  deﬁciência  auditiva  sensorioneural  não
sindrômica.
Objetivo: A  ﬁnalidade  do  nosso  estudo  foi  investigar  a  incidência  dessas  mutac¸ões  no  DNA
mitocondrial  nessa  populac¸ão.
Método:  No  total,  178  pacientes  esporádicos  com  deﬁciência  auditiva  sensorioneural  não  sin-
drômica foram  recrutados  para  participac¸ão  no  estudo.  O  DNA  genômico  foi  extraído  de  amostra
de sangue  periférico.  Utilizamos  o  método  de  sequenciamento  SNaPshot® para  detecc¸ão  de
cinco mutac¸ões  do  DNA  mitocondrial:  A1555G  e  A827G  no  gene  12S  rRNA  e  A7445G,  7472insC
e T7511C  no  gene  tRNASer(UCN).  Paralelamente,  utilizamos  a  reac¸ão  de  polimerase  em  cadeia  e
sequenciamos  os  produtos  para  triagem  das  mutac¸ões  no  gene  GJB2  nos  pacientes  portadores
de mutac¸ões  no  DNA  mitocondrial.
Resultados:  Em  nossa  populac¸ão,  não  conseguimos  detectar  a  presenc¸a  da  mutac¸ão  A1555G  no
gene 12S  rRNA  e  nem  as  mutac¸ões  A7445G,  7472insC  e  T7511C  no  gene  tRNASer(UCN).  Entretanto,
constatamos  que  seis  pacientes  (3,37%)  eram  portadores  da  mutac¸ão  homozigota  A827G;  e  um
deles também  portava  a  mutac¸ão  homozigota  GJB2  235delC.
Conclusão:  Nossos  achados  no  presente  estudo  indicam  que,  mesmo  em  pacientes  esporádi-
cos com  deﬁciência  auditiva  sensorioneural  não  sindrômica,  as  mutac¸ões  do  DNA  mitocondrial
também podem  contribuir  para  o  fenótipo  clínico.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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was  recorded.  Patients  with  dominant  family  history,  a  his-ntroduction
ensorineural  hearing  loss  (SNHL)  is  one  of  the  most  com-
on  congenital  disorders.  The  incidence  is  approximately
ne  in  1000  newborns  worldwide.1--3 Over  half  of  them  have
 genetic  cause  with  autosomal  dominant,  autosomal  reces-
ive,  X-linked  or  mitochondrial  pattern  of  inheritance.4,5 Up
o  now,  more  than  200  point  mutations  in  mitochondrial
NA  (mtDNA)  have  been  reported  in  the  mtDNA  mutation
atabase  MITOMAP.6 Among  them,  several  mutations  have
een  found  to  be  associated  with  syndromic,  nonsyndromic
nd  aminoglycoside-induced  hearing  loss,  especially  those
n  12S  rRNA  and  tRNASer(UCN) genes.  The  A1555G,  which  is
ocated  in  the  highly  conserved  A-site  of  mitochondrial  12S
RNA,  was  the  ﬁrst  one  to  be  described  to  be  associated  with
NHL  and  found  to  be  responsible  for  both  aminoglycoside-
nduced  and  nonsyndromic  hearing  loss  in  several  families
orldwide.7--10 The  A827G,  a  homoplasmic  mutation  in
tDNA  12S  rRNA,  was  recently  found  to  be  responsible  for
onsyndromic  hearing  loss  in  all  maternally  related  family
embers  in  a  Chinese  family.11 It  also  has  been  reported  to
e  associated  with  both  aminoglycoside-ototoxicity  and  non-
yndromic  hearing  loss  in  sporadic  individuals.12,13 Besides
he  12S  rRNA  gene,  the  mitochondrial  tRNASer(UCN) gene  is
lso  associated  with  SNHL,  as  well  as  with  nonsyndromic
eafness,  as  several  mutations  have  been  identiﬁed,  includ-
ng  A7445G,14,15 7472insC,16 T7511C.17,18
Although,  as  mentioned  above,  mtDNA  mutations  have
een  reported  to  be  associated  with  nonsyndromic  SNHL
t
l
wn  several  families,  little  is  known  about  the  incidence  of
hese  mtDNA  mutations  in  sporadic  patients  with  nonsyn-
romic  SNHL.  Our  previous  study  was  focused  on  the  GJB2
nd  SLC26A4  mutations  in  patients  with  autosomal  reces-
ive  nonsyndromic  hearing  loss  (ARNHL).  Consequently,  we
nd  that  although  the  GJB2  and  SLC26A4  gene  are  the  most
ommon  deafness  genes,  only  a  small  part  of  these  patients
arry  homozygous  or  compound  heterozygous  pathogenic
utations.19 That  indicates  that  other  deafness  genes  may
ontribute  to  the  clinical  phenotype.  In  this  study  we  used  a
apid  method,  SNaPshot® sequencing,  to  screen  178  sporadic
atients  with  nonsyndromic  SNHL  to  estimate  the  preva-
ence  of  mtDNA  mutations  in  such  population.  Moreover,  to
dentify  the  role  of  the  GJB2  gene  in  the  deafness  phe-
otype,  we  also  screened  the  GJB2  gene  in  the  patients
arrying  mtDNA  mutations.
ethods
atients  and  samples
 total  of  178  sporadic  patients  with  nonsyndromic  SNHL
articipated  in  this  investigation.  They  originated  from  var-
ous  regions  of  our  province.  Each  patient  received  careful
hysical  examination,  and  a  comprehensive  clinical  historyory  of  aminoglycoside  exposure,  and  syndromic  hearing
oss  were  excluded  from  the  study.  All  subjects  under-
ent  audiometric  testing  including  auditory  brain-stem
mtDNA  mutations  in  sporadic  patients  with  SNHL  393
Table  1  PCR  primer  sequences.
Gene  PCR  primers  Predicted  size
12S  rRNA
A1555G  F:  5′-GCATCAAGCACGCAGCAATG-3′ 926  bp
A827G R:  5′-TAGGTTTAGCTCAGAGCGGTCAAGTTA-3′
tRNASer(UCN)
A7445G  F:  5′-CCCCCACCCTACCACACATTC-3′ 524  bp
7472insC R:  5′-GGTGTACTCGTAGGTTCAGTACCATTGG-3′
T7511C
GJB2
Exon  1 F:  5′-TGGGGAACTCATGGGGGCTCAAAG-3′ 425  bp
R: 5′-AGGTTCCTGGCCGGGCAGTCC-3′
Exon  2  F:  5′-TCAGAGAAGTCTCCCTGTTCTGTCC-3′ 916  bp
R: 5′-TGAGGCCTACAGGGGTTTCAA-3′
Table  2  Extension  primer  sequences.
Gene  Extension  primers
12S  rRNA
A1555G  R:  5′-TTTTTTTTTTTTTAACCCCTACGCATTTATATAGAGGAG-3′
A827G  R:  5′-TTTTTTTTTTCACGGGAAACAGCAGTGATTA-3′
tRNASer(UCN)
A7445G  5′-TTTTTTTTTTTTTTTTTTTTTTTTATTCGAAGAACCCGTATACATAAAATCTAG-3′
7472insC  F:  5′-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAAGGAATCGAACCCCCCA-3′
TTTT
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aT7511C  F:  5′-TTTTTTTTTTTTTTTTT
response  (ABR),  otoacoustic  emissions  (OAE)  and  tympa-
nometry.  The  severity  of  hearing  impairment  was  deﬁned
as  normal  (<26  dB),  mild  (26--40  dB),  moderate  (41--70  dB),
severe  (71--90  dB)  and  profound  (>90  dB).  Peripheral  blood
samples  were  obtained  from  the  patients  for  genomic  DNA
isolation.
Informed  consent  was  obtained  from  adult  patients  and
from  the  parents  of  children,  and  this  study  was  approved  by
local  Ethics  Committee  (Ethical  Committee  approval  num-
ber:  2013--007).
SNaPshot® sequencing
A  ﬁnal  20  L  PCR  reaction  mixture  contained  1×  GC  Buffer
I,  3.0  mM  Mg2+;  0.3  mM  dNTPs,  1  U  HotStarTaq  polymerase,
10  ng  template  DNA,  and  1  M  primer  mixture,  including  two
pairs  of  primers  to  amplify  ﬁve  mutation  regions  (Table  1).
The  PCR  conditions  were  as  follows:  95 ◦C  for  2  min;  11  cycles
of  94 ◦C  for  20  s,  65--0.5 ◦C  per  cycle  for  40  s,  72 ◦C  for  90  s;  24
cycles  of  94 ◦C  for  20  s,  59 ◦C  for  30  s,  72 ◦C  for  90  s;  72 ◦C  for
2  min.  For  puriﬁcation  of  PCR  products,  5  U  shrimp  alkaline
phosphatase  (SAP)  (Promega)  and  2  U  Exonuclease  I  (Epicen-
tre)  were  added  into  15  L PCR  products.  The  mixture  was
incubated  at  37 ◦C  for  60  min,  followed  by  incubation  at  75 ◦C
for  15  min.The  single  base  extension  (SBE)  was  performed  in  a  ﬁnal
10  L  reaction  mixture,  containing  5  L  SNaPshot® Multiplex
Kit  (Applied  Biosystems),  2  L  puriﬁed  multiplex  PCR  prod-
uct,  and  0.8  M  extension  primer  mixture  (Table  2).  The
R
T
TTTTTTTTTTTTTTTTTCCCATGGCCTCCATGACTT-3′
eaction  program  was  96 ◦C  for  1  min;  28  cycles  of  96 ◦C  for
0  s,  52 ◦C  for  5  s,  60 ◦C  for  30  s;  4 ◦C  forever.  Then,  the  SBE
roducts  were  puriﬁed  by  using  SAP.  For  sequence  analy-
is,  0.5  L  puriﬁed  multiplex  SBE  products  were  mixed  with
.5  L  Liz120  SIZE  STANDARD  (Applied  Biosystems)  and  9  L
i-Di  (Applied  Biosystems),  and  denatured  at  95 ◦C  for  5  min.
hen,  the  products  were  sequenced  by  the  ABI  3730XL  DNA
equencer.  The  data  was  analyzed  by  the  GeneMapper  v4.1
oftware  (Applied  Biosystems).
JB2  mutation  detection  by  polymerase  chain
eaction
wo  exons  of  GJB2  were  ampliﬁed  from  DNA  samples  by
olymerase  chain  reaction  (PCR).  The  primers  were  listed
n  Table  1.  PCR  ampliﬁcation  and  subsequent  puriﬁcation
ere  performed  as  we  described  before.  The  puriﬁed  PCR
roducts  were  sequenced  using  the  dideoxy  chain  terminator
ethod  on  an  ABI  3730XL  DNA  sequencer  (Applied  Biosys-
ems)  with  the  ABI  Big  Dye  Terminator  v3.1  Cycle  Sequencing
it  (Applied  Biosystems),  according  to  the  manufacturer’s
rotocols.  The  primers  were  the  same  as  those  for  the  PCR
mpliﬁcation.esults
he  study  samples  consisted  of  82  males  and  96  females.
he  age  of  all  participants  ranged  from  9  months  to  37
394  Jiang  H  et  al.
Table  3  Clinical  and  genetic  characteristics  of  six  patients  carrying  A827G  in  mtDNA  12S  rRNA.
Patient  Sex  Age  of  onset  (years)  Level  of  hearing  impairment  A827G  in  mtDNA  12S  rRNA  Mutations  in  GJB2
Right  Left
#61  Male  0  Profound  Profound  +/+  235delC/235delC
#105 Female  0  Profound  Profound  +/+  WT/WT
#131 Female  0  Profound  Profound  +/+  WT/WT
#140 Female  0  Profound  Profound  +/+  WT/WT
#197 Female  0  Profound  Profound  +/+  WT/WT
#210 Male  0  Profound Profound  +/+  WT/WT
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aears,  with  a  mean  age  of  5.53  ±  4.44  years.  The  results
f  audiometric  testing  revealed  cochlear  involvement  in
ll  participants  and  that  all  of  them  suffered  from  severe
71--90  dB  to  profound  (>90  dB))  bilateral  sensorineural  hear-
ng  impairment.
In  all  178  sporadic  patients  with  nonsyndromic  SNHL,
e  failed  to  detect  the  presence  of  the  A7445G,  7472insC,
7511C  mutations  in  the  tRNASer(UCN) gene.  Moreover,  we  did
ot  detect  A1555G  mutation  in  the  12S  rRNA  gene  in  this
opulation.  However,  the  A827G  variant  in  the  12S  rRNA
ene  was  found  in  6  patients,  who  all  carried  homozygous
utation.  To  illuminate  the  role  of  the  GJB2  gene  in  the
henotypic  expression  in  the  individuals  with  mtDNA  muta-
ions,  we  screened  the  GJB2  gene  mutations  in  the  subjects
arrying  A827G  mutation.  Consequently,  only  one  patient,
ho  had  homozygous  235delC,  carried  pathogenic  mutation
n  the  GJB2  gene  (Table  3).
iscussion
ost  of  the  previously  reported  studies  focused  on  the
ssociation  between  the  mtDNA  mutations  and  the  pop-
lation  with  aminoglycoside-induced  and/or  nonsyndromic
earing  loss.12,19 Several  mtDNA  mutations,  such  as  A1555G
nd  A827G  in  the  12S  rRNA  gene,  A7445G,  7472insC  and
7511C  in  the  tRNASer(UCN) gene  have  been  identiﬁed  to  be
ssociated  with  such  populations.10,13,14,19,20 However,  these
utations  are  often  not  sufﬁcient  to  produce  the  clinical
henotype.14,19 In  patients  with  ARNHL,  similar  with  other
tudies,  our  previous  study  found  that  about  30--40%  patients
arried  pathogenic  mutations  in  the  most  common  deafness
enes,  but  nearly  40%  of  these  patients  carried  heterozygous
utation.  Thus,  other  gene  mutations  may  together  con-
ribute  to  the  phenotype.  Although  the  association  between
he  mtDNA  mutations  and  nonsyndromic  hearing  loss  has
een  identiﬁed  in  several  families,  little  is  known  about  the
revalence  of  mtDNA  mutations  in  sporadic  patients  with
onsyndromic  SNHL.
Mitochondrial  DNA  mutations  in  tRNA  genes  can  cause
RNA  modiﬁcation  and  a  failure  in  tRNA  metabolism,  thus
mpairing  the  protein  synthesis  and  reducing  the  ATP  syn-
hesis,  which  are  considered  to  be  the  main  pathogenic
actors.21--25 The  A7445G  mutation  was  ﬁrst  identiﬁed  in  a
amily  with  nonsyndromic  deafness.26 This  mutation  leads  to
he  3′ end  endonucleolytic  processing  defect  in  the  L-strand
olycistronic  RNA  precursor.27 Consequently,  the  A7445G
s
p
1
lutation  can  cause  a  reduction  of  more  than  50%  in  the
RNASer(UCN) level  and  a  decrease  in  protein  synthesis,  play-
ng  a  determinant  role  in  the  respiratory  phenotype  of  the
utant  cell  lines.28,29 The  7472insC  was  originally  reported
y  Tiranti  et  al.,  which  is  likely  to  alter  the  structure  of  the
 psi  C  loop  in  the  tRNASer(UCN) clover  leaf  secondary  struc-
ure,  and  has  been  proved  to  impair  both  5′ and  3′ processing
f  the  tRNASer(UCN) and  cause  a  drop  in  the  steady-state
evel  of  the  tRNASer(UCN).16,24,30 The  T7511C  mutation  has
een  identiﬁed  to  be  associated  with  nonsyndromic  hearing
oss  in  several  different  ethnic  families.17,18,31 This  muta-
ion  can  affect  the  processing  of  L-strand  RNA  precursor,
panning  tRNASer(UCN) as  well  as  ND6  mRNA,  speciﬁcally  in
he  5′ end  of  tRNA.23,32 As  a  result,  the  T7511C  mutation
auses  a reduction  of  the  level  of  tRNASer(UCN) and  an  impair-
ent  in  mitochondrial  protein  synthesis.22,28 Although  these
utations  in  the  tRNASer(UCN) have  been  found  to  be  associ-
ted  with  the  patients  with  aminoglycoside-induced  and/or
onsyndromic  hearing  loss,  many  studies  failed  to  detect
uch  mutations  in  those  patients.  In  the  study  reported
y  Xing  et  al.,  they  analyzed  the  molecular  characteriza-
ion  of  a  Chinese  family  with  aminoglycoside-induced  and
onsyndromic  hearing  loss,  but  did  not  ﬁnd  the  A7445G,
472insC,  and  T7511C  mutations  in  the  tRNASer(UCN) gene.33
n  an  Argentinean  family  with  aminoglycoside-induced  hear-
ng  loss,  such  mutations  were  also  not  found.34 Moreover,
i  et  al.  performed  a molecular  analysis  in  164  unrelated
aucasian  individuals  with  nonsyndromic  hearing  impair-
ent  and  failed  to  detect  the  presence  of  the  A7445G,
472insC,  and  T7511C  mutations  in  the  tRNASer(UCN) gene.12
breu-Silva  et  al.  also  did  not  ﬁnd  these  mutations  in
03  unselected  Brazilian  hearing-impaired  patients.35 Up  to
ow,  little  is  known  about  the  incidence  of  these  muta-
ions  in  the  tRNASer(UCN) gene  in  sporadic  patients  with
onsyndromic  SNHL.  In  the  present  study,  we  explored
hese  mutations  in  such  population,  but  none  of  these  sub-
ects  was  found  to  carry  such  mutations  in  the  tRNASer(UCN)
ene.
The  A1555G  mutation  creates  a  speciﬁc  GC  base  pair,
hich  makes  the  secondary  structure  of  mitochondrial  12S
RNA  more  closely  resembling  the  corresponding  region  of
.  coli  16S  rRNA  and  binding  aminoglycosides  with  high
fﬁnities.36 Thus,  the  patients  carrying  this  mutation  can
uffer  from  SNHL  after  using  aminoglycosides.13 However,
revious  studies  have  identiﬁed  that  A1555G  mutation  in
2S  rRNA  is  also  associated  with  nonsyndromic  hearing
oss,9,10 while  the  incidence  in  nonsyndromic  hearing  loss  is
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much  lower  than  in  aminoglycoside-induced  hearing  impair-
ment.  Lu  et  al.  reported  that  the  incidences  of  the  A1555G
mutation  were  1.43%  and  10.41%  in  a  Chinese  pediatric
population  with  nonsyndromic  and  aminoglycoside-induced
hearing  loss,  respectively.19 Similarly,  in  a  Polish  popula-
tion,  Rydzanicz  et  al.  observed  that  the  incidence  was  5.5%
and  1.6%  in  the  cohorts  with  aminoglycoside-induced  and
nonsyndromic  hearing  loss.37 In  a  Caucasian  pediatric  non-
syndromic  hearing  loss  population,  the  frequency  of  the
A1555G  mutation  was  0.6%.12 In  this  study,  we  found  that
none  of  the  subjects  carried  the  A1555G  mutation.  Com-
pared  with  previous  reports,  the  incidence  of  the  A1555G
mutation  in  our  population  with  nonsyndromic  SNHL  is  rela-
tively  lower.
The  A827G  mutation,  like  A1555G  mutation,  is  located
at  the  A-site  of  the  mitochondrial  12S  rRNA  gene,  which
is  highly  evolutionarily  conserved  in  different  species.34 It
is  possible  that  the  alteration  of  the  tertiary  or  quater-
nary  structure  of  the  12S  rRNA  by  the  A827G  mutation
may  lead  to  mitochondrial  dysfunction;  thereby,  it  would
play  a  role  in  the  pathogenesis  of  hearing  loss.11,34 The
pathogenesis  of  this  mutation  has  been  identiﬁed  in  a  Chi-
nese  family  with  nonsyndromic  hearing  loss.11 Although  the
A827G  mutation  was  also  found  in  normal  hearing  controls,19
more  studies  consider  it  as  a  pathogenic  mutation  depend-
ing  on  its  location  and  absence  in  the  controls  in  their
studies.11--13,34,37 Meanwhile,  these  studies  also  found  incom-
plete  penetrance  of  the  A827G  mutation,  which  indicates
that  this  mutation  alone  is  not  sufﬁcient  to  produce  clinical
phenotype.11,34 Thus,  some  normal  hearing  subjects  carrying
the  A827G  mutation  may  be  attributed  to  incomplete  pen-
etrance.  In  our  study,  we  found  that  3.37%  (6/178)  patients
carry  homozygous  A827G  mutation.  In  another  Chinese  spo-
radic  pediatric  population  with  nonsyndromic  hearing  loss,
the  incidence  is  4.41%.13 The  incidence  of  the  A827G  muta-
tion  in  such  Chinese  population  seems  to  be  higher  than
in  other  ethnic  groups.11,37 As  previous  studies  showed  that
expression  of  the  clinical  phenotype  of  deafness-associated
homoplasmic  mutations  in  the  12S  rRNA  gene  requires  the
contribution  of  modulating  factors,  including  aminoglyco-
sides  or  nuclear  modiﬁer  genes,  and  the  GJB2  gene  is
a  potential  candidate  modiﬁer  gene,12,38--40 we  performed
mutational  screening  of  the  GJB2  gene  in  the  patients  car-
rying  the  A827G  mutation.  As  a  result,  only  one  patient
carried  both  12S  rRNA  A827G  mutation  and  homozygous
GJB2  235delC  mutation.  The  lack  of  GJB2  mutation  in  other
patients  indicates  that  other  nuclear  modiﬁer  genes  and
other  environmental  factors  may  contribute  to  the  clinical
phenotype  in  these  patients.
Conclusion
In  the  present  study  we  screened  mtDNA  mutations  in  spo-
radic  patients  with  nonsyndromic  SNHL  and  found  a  total
of  6  subjects  (3.37%)  carrying  homozygous  mtDNA  muta-
tions.  Our  ﬁndings  indicate  that  even  sporadic  patients  with
nonsyndromic  SNHL  also  carry  mtDNA  mutations  and  these
mutations  might  contribute  to  the  clinical  phenotype.  Fur-
ther  studies  screening  the  mutations  in  mtDNA  are  needed
to  help  us  understand  the  prevalence  and  role  of  mtDNA
mutations  in  sporadic  patients  with  nonsyndromic  SNHL.
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